Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal Misoprostol vs Hyoscine in Hysteroscopy
NCT03359655Completed
- Sponsor
- Bezmialem Vakif University
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of misoprostol and hyoscine butylbromide in endometrial polyp, Submucosal Uterine Leiomyoma and uterine synechiae (IUA) (3 arms), sponsored by Bezmialem Vakif University. Primary endpoint: Postoperative pain at 2 hours. Started Jun 2018; status: completed.
02
Drugs
misoprostolhyoscine butylbromide
03
Conditions
endometrial polypSubmucosal Uterine Leiomyomauterine synechiae (IUA)
Beyond the preview
Go deeper on NCT03359655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03359655.